What Happened?
Braintree, MA-based Haemonetics Appointed Anila Lingamneni as Executive Vice President and Chief Technology Officer
About the Company
We believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. We seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. Working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right dose to the patient who does.
About the Person
Anila Lingamneni is Executive Vice President and Chief Technology Officer at Haemonetics. Previously, Anila held various senior IT leadership roles in the industry.
Info Source
News
Short Profile